Press Releases

Date	Title
2/24/20	Vir Biotechnology to Present at 40th Annual Cowen Healthcare Conference
2/12/20	Vir Biotechnology Identifies Two Antibodies That Bind to the Spike Protein of 2019-nCoV, Newly Named as SARS-CoV-2
1/22/20	Vir Biotechnology applying multiple platforms to address public health risk from Wuhan coronavirus
1/13/20	Vir Biotechnology to Provide Pipeline Update at 38th Annual J.P. Morgan Healthcare Conference
1/7/20	Vir Biotechnology to Present at 38th Annual J.P. Morgan Healthcare Conference

Vir - Investor Relations Menu